Navigation Links
Relief from cancer pain with anticonvulsants

A new study by researchers at the A & A Pain Institute in St Louis, Missouri(A & A stands for Analgesia: pain reduction & Algology: the study of pain), have found that an anticonvulsant drug levetiracetam brings dramatic relief to nerve pain caused by cancer. In a study of seven patients between 39 and 67 who had severe nerve pain related to cancer, which is caused by the tumor pressing on the nerve, analgesic drugs were not effective in relieving the pain. For the study, they were given along with injected narcotics, varying doses of levetiracetam over periods// ranging from two days to two weeks. Doses varied between 500 milligrams and 1,500 milligrams depending upon the patient response.

Researchers said they witnessed dramatic results in all seven patients who reported improved pain relief with scores going down from 8 to 10 to zero to three and they also found that the participants tolerated the drug well without any adverse effects.

Page: 1

Related medicine news :

1. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
2. Relief from common back pain
3. Relief to pregnant women using fertility drugs
4. Relief of pain for suffering patients
5. Relief from Migraine
6. Pain Relief For Osteoarthritis Patients
7. Relief From Migraines
8. Effective Pain Relief For Patients Suffering From Multiple Sclerosis
9. Drug Found To Bring Relief For Individuals With Early Parkinson’
10. Relief For Women Suffering From Fibromyalgia
11. Lemons Could Give Relief For Patients Suffering From Asthma
Post Your Comments:

(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017   Montrium ... Master File solutions, today—from the IQPC Trial Master ... , NL)—announced that EastHORN Clinical Services has ... clinical programs and TMF management. EastHORN, a leading ... eTMF platform to increase transparency to enable greater ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017   ... for global supply chains, has published the first annual edition of its ... of more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings ... 2016. ... CSR Risk & Performance Index ...
Breaking Medicine Technology: